Novel perspectives in fetal biomarker implementation for the noninvasive prenatal testing.
Noninvasive prenatal testing (NIPT) utilizes cell-free fetal DNA (cffDNA) present in maternal peripheral blood to detect chromosomal abnormalities. The detection of 21-trisomy, 18-trisomy, and 13-trisomy in the fetus has become a common screening method during pregnancy and has been widely applied i...
| Publicado en: | Critical Reviews in Clinical Laboratory Sciences Vol. 56; no. 6; pp. 374 - 393 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
Sep2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |